Lextro Bio Solutions
Hyderabad, India· Est.
Integrated CRO delivering full‑spectrum drug discovery services across oncology, infectious disease and metabolic disorders.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Integrated CRO delivering full‑spectrum drug discovery services across oncology, infectious disease and metabolic disorders.
OncologyInfectious DiseaseAutoimmuneMetabolic Disorders
Technology Platform
Recombinant protein expression (bacterial & mammalian), multi‑modal antibody discovery, high‑throughput in‑vitro screening, and AAALAC‑accredited in‑vivo pharmacology models across oncology, autoimmune, infectious and metabolic indications.
Opportunities
Rising demand for cost‑effective, end‑to‑end CRO services in Asia and the company’s integrated platform position it to capture new biotech and pharma contracts.
Risk Factors
Intense competition from global CROs and the need for continuous technology upgrades may pressure margins and market share.
Competitive Landscape
Competes with both domestic and international CROs; differentiation stems from its comprehensive suite of services, AAALAC accreditation, and strategic location in Genome Valley.